Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David H. Adams, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Michael J. Reardon, MD
The Methodist Hospital Research Institute
Principal Investigator - Nicolas M. Van Mieghem, MD
Erasmus Medical Center
Study Chair - Patrick W. Serruys, MD, PhD
National Heart & Lung Institute of Imperial College in London
Study Chair - Rüdiger Lange, MD, PhD
Deutsches Herzzentrum München
Principal Investigator - Stephan Windecker, MD, PhD
Bern University Hospital
Principal Investigator - Thomas Walther, MD, PhD
Kerckhoff Klinik
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
86 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- London Health Sciences Centre, University Hospital
London, Ontario, Canada
- Sunnybrook Research Institute
Toronto, Ontario, Canada
- Toronto General Hospital (university Health Network)
Toronto, Ontario, Canada
- Mcgill University Health Center - Royal Victoria Hospital
Montreal, Quebec, Canada
- Montreal Heart Institute
Montreal, Canada
- Rigshospitalet
Copenhagen, Denmark
- Universitäts-Herzzentrum Freiburg • Bad Krozingen
Bad Krozingen, Germany
- Universitätsklinikum Bonn
Bonn, Germany
- Deutsches Herzzentrum Muenchen
Munich, Germany
- Amphia Hospital Breda
Breda, Netherlands
- Medisch Centrum Leeuwarden
Leeuwarden, Netherlands
- St. Antonius Hospital, R & D Cardiology
Nieuwegein, Netherlands
- Erasmus Medical Center - Rotterdam
Rotterdam, Netherlands
- Servicio de Cardiologia del Hospital Virgen de la Victoria
Málaga, Spain
- Hospital Universitario Central de Asturias
Oviedo, Spain
- Karolinska Universitetssjukhuset Stockholm
Stockholm, Sweden
- Bern University Hospital
Bern, Switzerland
- Universitatsspital Zurich
Zurich, Switzerland
- Leeds General Infirmary
Leeds, United Kingdom
- Glenfield Hospital, Leicester, Uk
Leicester, United Kingdom
- St. George'S Hospital London
London, United Kingdom
- Banner Good Samaritan Medical Center
Phoenix, Arizona, United States
- Cedars-Sinai Medical Center
Hollywood, California, United States
- Scripps Green Hospital
La Jolla, California, United States
- Keck Medical Center of Usc
Los Angeles, California, United States
- El Camino Hospital
Mountain View, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Southern California Permenente Medical Group
Pasadena, California, United States
- Stanford University Medical Center
Stanford, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Washington Hospital Center
Washington D.C., District of Columbia, United States
- Morton Plant Hospital
Clearwater, Florida, United States
- University of Miami
Coral Gables, Florida, United States
- Delray Medical Center
Delray Beach, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Piedmont Healthcare, Inc.
Atlanta, Georgia, United States
- the Queen'S Medical Center
Honolulu, Hawaii, United States
- Loyola University of Chicago
Maywood, Illinois, United States
- St. Vincent Heart Center of Indiana
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Jul 2018
- Completion
- 30 Nov 2026
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 1,746
- Registry id
- NCT01586910
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.